U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H19N.ClH
Molecular Weight 261.79
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEFETAMINE HYDROCHLORIDE

SMILES

Cl.CN(C)[C@H](CC1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=VKIHKZMKDNVEIK-PKLMIRHRSA-N
InChI=1S/C16H19N.ClH/c1-17(2)16(15-11-7-4-8-12-15)13-14-9-5-3-6-10-14;/h3-12,16H,13H2,1-2H3;1H/t16-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C16H19N
Molecular Weight 225.3288
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/16991666 | https://www.ncbi.nlm.nih.gov/pubmed/26276083 | https://www.ncbi.nlm.nih.gov/pubmed/1417455

Lefetamine (L-SPA; L-1,2-diphenyl-l-dimethylaminoethane hydrochloride) is a synthetic compound with analgesic and anti-inflammatory action, introduced in clinical practice in Italy and Japan as ‘Santenol’. Santenol is available for oral (50 mg tablets1 and intramuscular (60 mg vials containing also lidocainel use. Animal studies have shown an analgesic effect and changes in EEG activity and O2 consumption of the nervous tissue. Lefetamine may be an opioid partial agonist. Lefetamine was first marketed in the 1940s as an opioid analgesic. Since withdrawal symptoms were observed during treatment, it became a controlled substance.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.
2006 Nov 15
Patents

Patents

Sample Use Guides

In clinical trial patients were assigned to lefetamine treatment programme. After stabilization on admission with a sufficient lefetamine dosage (mean 450 mg/day) five of them underwent a progressive lefetamine withdrawal with increasing sedative-antimanic therapy (neuroleptics such as levopromazine, chlorpromazine or sodium valproatel.
Route of Administration: Oral
Incubation mixtures (final volume: 50 mkL) consisted of 90 mM phosphate buffer (pH 7.4), 5 mM Mg2+, 5 mM isocitrate, 1.2 mM NADP+, 0.5 U/mL isocitrate dehydrogenase, 200 U/mL superoxide dismutase, liver enzymes and the LEFETAMINE (up to 1000mkM), diluted in the phosphate buffer. Reactions were started by addition of the ice-cold microsomes and stopped with 50 mkL of an ice-cold mixture of acetonitrile, containing the IS (diphenhydramine, 10 mkM). The solutions were centrifuged for 2 min at 14,000 x g, 50 mkL of the supernatant was transferred to an autosampler vial and injected onto the LC–MSn system.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:17:27 UTC 2023
Edited
by admin
on Fri Dec 15 15:17:27 UTC 2023
Record UNII
XYT5RKF8JA
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEFETAMINE HYDROCHLORIDE
JAN   MART.   MI   WHO-DD  
Common Name English
LEFETAMINE HCL
Common Name English
SPA (ANALGESIC)
Common Name English
(R)-N,N-DIMETHYL-1,2-DIPHENYLETHYLAMINE HYDROCHLORIDE
Systematic Name English
1,2-DIPHENYL-1-DIMETHYLAMINOETHANE HYDROCHLORIDE, L-
Common Name English
LEFETAMINE HYDROCHLORIDE [JAN]
Common Name English
LEFETAMINE HYDROCHLORIDE [MART.]
Common Name English
(-)-N,N-DIMETHYL-1,2-DIPHENYLETHYLAMINE HYDROCHLORIDE
Systematic Name English
Lefetamine hydrochloride [WHO-DD]
Common Name English
LEFETAMINE HYDROCHLORIDE [MI]
Common Name English
Classification Tree Code System Code
DEA NO. 1635
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
Code System Code Type Description
PUBCHEM
443969
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
MERCK INDEX
m1201
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY Merck Index
CAS
14148-99-3
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
ChEMBL
CHEMBL2106355
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
CAS
24361-76-0
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
ALTERNATIVE
FDA UNII
XYT5RKF8JA
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
SMS_ID
100000086644
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
EPA CompTox
DTXSID00931103
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
EVMPD
SUB02884MIG
Created by admin on Fri Dec 15 15:17:27 UTC 2023 , Edited by admin on Fri Dec 15 15:17:27 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY